A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)Victoria Atkinson, Bart Neyns, Massimo Aglietta et al.|Cancers|2021Cited by 10